Therapeutic possibilities of sodium chloride saline solutions in relieving symptoms of exacerbation of chronic rhinosinusitis

Introduction. Chronic rhinosinusitis accompanied by nasal breathing difficulty, nasal discharge, hyposmia and facial pain is a common disease.

Aim. To study the corrective role of 0.08% sodium hypochlorite and 2.1% hypertonic solution in relieving symptoms of exacerbation of chronic rhinosinusitis and improving the patients’ quality of life.

Materials and methods. A total of 79 patients (aged 18 to 63 years) diagnosed with chronic rhinosinusitis, exacerbation (ICD-10 code: J32) were enrolled in the study. The patients were divided into two groups. The control group received a standard treatment for exacerbations of chronic rhinosinusitis based on clinical guidelines. In addition to the course of conservative therapy, patients of the treatment group received an antiseptic nasal spray containing sodium hypochlorite at a concentration of ≤ 0.08%, 2.1% sodium chloride, 0.05% lithium magnesium sodium silicate and purified water. The patients’ life distress index was assessed based on data collected using the PSOM-31 questionnaire. The follow-up visits were Days 5 and Day 10 of treatment.

Results and discussion. The patients of Group 2 reported the greatest changes in the severity of nasal symptoms at Day 10 of treatment, which amounted to 6.2 scores, whereas in Group 1 they amounted to 10.7 scores. At Day 10, the most disturbing general symptoms were reported by the patients of Group 1 as compared to the patients of Group 2: 16 vs 18.3 scores, respectively. Emotional deficiencies were less pronounced on Day 10 in patients of Group 2 (7 scores) as compared to Group 1 (8.7 scores).

Conclusion. Addition of a sodium hypochlorite-based agent containing 2.1% hypertonic sodium chloride solution to the standard therapy for exacerbations of chronic rhinosinusitis improves the patients’ well-being indices. Assessment of the survey results using the PSOM-31 questionnaire shows the maximal reduction in symptom severity and improvement of well-being indices on Day 10 of treatment, which confirms the accumulation of therapeutic effects of the antiseptic agent.

1. Krivopalov AA. Rhinosinusitis: classification, epidemiology, etiology and treatment. Meditsinskiy Sovet. 2016;(6):22–25. (In Russ.) https://doi.org/10.21518/2079-701X-2016-6-22-25.

2. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl. 29):1–464. https://doi.org/10.4193/Rhin20.600.

3. Korkmazov MYu, Yastremsky AP, Kornova NV, Lengina MA, Korkmazov AM. Therapeutic and diagnostic approaches in the treatment of chronic tonsillitis. Meditsinskiy Sovet. 2022;16(20):90–99. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-20-90-99.

4. Ivanchenko OA, Lopatin AS. Chronic rhinosinusitis: epidemiology, classification, etiology, and pathogenesis. The current view of the problem. Vestnik Oto-Rino-Laringologii. 2012;77(2):91–96. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2012/2/030042-46682012222.

5. Korkmazov MYu, Kornova NV, Lengina MA, Smirnov AA, Korkmazov AM, Dubinets ID. Effective antibiotic therapy for community-acquired otorhinolaryngological respiratory infection (clinical description). Meditsinskiy Sovet. 2022;16(20):73–81. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-20-73-81.

6. Dietz de Loos D, Lourijsen ES, Wildeman MAM, Freling NJM, Wolvers MDJ, Reitsma S, Fokkens WJ. Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology. J Allergy Clin Immunol. 2019;143(3):1207–1214. https://doi.org/10.1016/j.jaci.2018.12.986.

7. Korkmazov MYu, Kazachkov EL, Lengina MA, Dubinets ID, Korkmazov AM. Cause-effect factors of rhinosinusitis poliposa development. Russian Rhinology. 2023;31(2):124–130. (In Russ.) https://doi.org/10.17116/rosrino202331021124.

8. Lazareva AM, Smirnova OV. Immunological features of different phenotypes in chronic rhinosinusitis. Medical Immunology (Russia). 2025;27(2):275–286. (In Russ.) https://doi.org/10.15789/1563-0625-IFO-3026.

9. Sedaghat AR, Kuan EC, Scadding GK. Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors. J Allergy Clin Immunol Pract. 2022;10(6):1395–1403. https://doi.org/10.1016/j.jaip.2022.01.016.

10. Kato A, Schleimer RP, Bleier BS. Mechanisms and pathogenesis of chronic rhinosinusitis. J Allergy Clin Immunol. 2022;149(5):1491–1503. https://doi.org/10.1016/j.jaci.2022.02.016.

11. Bachert C, Marple B, Schlosser RJ, Hopkins C, Schleimer RP, Lambrecht BN et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020;6(1):86. https://doi.org/10.1038/s41572-020-00218-1.

12. Hildenbrand T, Milger-Kneidinger K, Baumann I, Weber R. The Diagnosis and Treatment of Chronic Rhinosinusitis. Dtsch Arztebl Int. 2024;121(19):643–653. https://doi.org/10.3238/arztebl.m2024.0167.

13. Пискунов ГЗ, Арефьева НА, Карпищенко СА, Карпова ЕП, Лопатин АС, Моисеева ЮП и др. Полипозный риносинусит: клинические рекомендации. 2022. 57 с. Режим доступа: http://rhinology.ru/wp-content/uploads/2022/10/ПРС-Клинические_рекомендации_финал.pdf.

14. Korkmazov MYu, Angelovich MS, Lengina MA, Belousov SYu. Clinical case of angiosarcoma of ethmoidal labyrinth and frontal sinus, issues of morphological verification of diagnosis. Vestnik Oto-Rino-Laringologii. 2022;87(4):102–106. (In Russ.) https://doi.org/10.17116/otorino202287041102.

15. Shumkova GL, Amelina EL, Krasovskiy SA, Krylova NA. Сhronic rhinosinusitis in adult patients with cystic fibrosis receiving CFTR modulators. Pulmonologiya. 2024;34(2):257–263. (In Russ.) https://doi.org/10.18093/0869-0189-2024-34-2-257-263.

16. Korkmazov MYu, Lengina MA, Korkmasov AM, Kravchenko AYu. Effect of post-COVID syndrome on the quality of life of patients with allergic rhinitis and eosinophilic phenotype of chronic polyposis rhinosinusitis. Medical Journal of the Russian Federation. 2023;29(4):277–290. (In Russ.) https://doi.org/10.17816/medjrf472079.

17. Smirnova OV, Markina AN, Parilova OV. Pathophysiological features of chronic IgE-mediated rhinosinusitis of bacterial etiology. Medical Immunology (Russia). 2024;26(1):27–36. (In Russ.) https://doi.org/10.15789/1563-0625-PFO-2634.

18. Zyryanova KS, Dubinets ID, Korkmazov MY, Solodovnik AV. Differentiated approach to the treatment of exudative otitis media with application mucoregulatory therapy in childhood. Rossiiskaya Otorinolaringologiya. 2014;(2):31–34. (In Russ.) Available at: https://elibrary.ru/ryyujp.

19. Zyryanova K, Dubinets I, Ershova I, Korkmazov M. Initial therapy for acute otitis media in children. Vrach. 2016;(1):43–45. (In Russ.) Available at: https://www.elibrary.ru/vrxvph.

20. Korkmazov MYu. The theory of bioresonance and the possibility of its application in ENT practice. Rossiiskaya Otorinolaringologiya. 2009;(2):92–96. (In Russ.) Available at: https://elibrary.ru/mgszax.

21. Shchetinin SA, Korkmazov MY, Gizinger OA, Kochengina SA, Sokol EV. Efficiency of therapy ofchronic recurrent adenoiditisfor the children of resident in city Chelyabinsk on results front active rhinomanometriaandcytokine profile of washings of from the surface of oesophageal amygdale. Bulletin of the Chelyabinsk Regional Clinical Hospital. 2015;(3):59–63. (In Russ.) Available at: https://elibrary.ru/yjjnhh.

22. Gizinger OA, Korkmazov MYu, Shchetinin SA. The specific aspects of anamnesis of children with chronic adenoiditis. Rossiiskaya Otorinolaringologiya. 2017;(3):24–29. (In Russ.) https://doi.org/10.18692/1810-4800-2017-3-24-29.

23. Dallas A, van Driel M, Morgan S, Tapley A, Henderson K, Oldmeadow C. Antibiotic prescribing for acute otitis media and acute sinusitis: a cross-sectional analysis of the ReCEnT study exploring the habits of early career doctors in family practice. Fam Pract. 2017;34(2):180–187. https://doi.org/10.1093/fampra/cmw144.

24. Korkmazov AM, Korkmazov MYu. Methods of correction of the functional infringements of phagocytes and local manifestations of oxidative stress in the multiple shell of the nose region with use of ultrasound cavitation. Russian Journal of Immunology. 2018;12(3):325–328. (In Russ.) https://doi.org/10.31857/S102872210002404-9.

25. Баранов АА, Намазова-Баранова ЛС, Лобзин ЮВ, Таточенко ВК, Усков АН, Куличенко ТВ и др. Острая респираторная вирусная инфекция (ОРВИ): клинические рекомендации. 2022. Режим доступа: https://cr.minzdrav.gov.ru/view-cr/25_2.

26. Kumar N, Brar T, Kita H, Marks LA, Miglani A, Marino MJ, Lal D. Viruses in chronic rhinosinusitis: a systematic review. Front Allergy. 2023;4:1237068. https://doi.org/10.3389/falgy.2023.1237068.

27. Khisamova AA, Gizinger OA, Kornova NV, Zyryanova KS, Korkmazov AM, Beloshangin AS. Studies of immunological and microbiological efficiency of the therapy of curcumin and methionine in the developed capsules. Russian Journal of Immunology. 2021;24(2):305–310. (In Russ.) https://doi.org/10.46235/1028-7221-1001-SOI.

28. Jiao J, Wang C, Zhang L. Epithelial physical barrier defects in chronic rhinosinusitis. Expert Rev Clin Immunol. 2019;15(6):679–688. https://doi.org/10.1080/1744666X.2019.1601556.

29. Chen Q, Tan KS, Liu J, Ong HH, Zhou S, Huang H et al. Host Antiviral Response Suppresses Ciliogenesis and Motile Ciliary Functions in the Nasal Epithelium. Front Cell Dev Biol. 2020;8:581340. https://doi.org/10.3389/fcell.2020.581340.

30. Korkmazov MYu. Chronic tonsillitis and analysis of physical methods of exposure. Vestnik Oto-Rino-Laringologii. 2006;(S5):299–300. (In Russ.) Available at: https://elibrary.ru/sicbel.

31. Jiao J, Yang J, Li J, Li Y, Zhang L. Hypertonic saline and seawater solutions damage sinonasal epithelial cell air-liquid interface cultures. Int Forum Allergy Rhinol. 2020;10(1):59–68. https://doi.org/10.1002/alr.22459.

32. He Y, Fu Y, Wu Y, Zhu T, Li H. Pathogenesis and treatment of chronic rhinosinusitis from the perspective of sinonasal epithelial dysfunction. Front Med. 2023;10:1139240. https://doi.org/10.3389/fmed.2023.1139240.

33. Korkmazov AM. The topical issues of the treatment of the patients presenting with rhinosurgical problems during the early postoperative period. Russian Rhinology. 2018;26(1):38–42. (In Russ.) https://doi.org/10.17116/rosrino201826138-42.

34. Gosepath J, Grebneva N, Mossikhin S, Mann WJ. Topical antibiotic, antifungal, and antiseptic solutions decrease ciliary activity in nasal respiratory cells. Am J Rhinol. 2002;16(1):25–31. Available at: https://www.sci-hub.ru/10.1177/194589240201600105.

35. Barshak MB, Durand ML. The role of infection and antibiotics in chronic rhinosinusitis. Laryngoscope Investig Otolaryngol. 2017;2(1):36–42. https://doi.org/10.1002/lio2.61.

36. Kryshtopava MA, Bizunkou AB. Nasal Lavage with Sodium Hypochlorite in Patients with Chronic Rhinosinusitis. Otorhinolaryngology. Eastern Europe. 2023;13(1):62–74. (In Russ.) https://doi.org/10.34883/PI.2023.13.1.026.

37. Krivopalov AA, Ryazantsev SV, Turieva VV. Local treatment of acute rhinosinusitis in the era of COVID-19. Meditsinskiy Sovet. 2022;16(20):53–63. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-20-53-63.

38. Ovchinnikov AYu, Miroshnichenko NA, Nikolaeva YuO. New Approaches to the Prevention of Bacterial Complications of the ENT Organs in Acute Respiratory Viral Infection. Effective Pharmacotherapy. 2024;20(3):24–30. (In Russ.) Available at: https://umedp.ru/articles/novye_podkhody_k_profilaktike_bakterialnykh_oslozhneniy_lororganov_pri_ostroy_respiratornoy_virusnoy.html.

39. Miroshnichenko NA, Nikolaeva YuO, Savranskaya KV, Ryzhkova NS. Maintaining Normal Indicators of Mucociliary Transport Is the Basis for the Adequate and Correct Use of Local Antiseptics. Effective Pharmacotherapy. 2024;20(16):10–13. (In Russ.) Available at: https://umedp.ru/articles/sokhranenie_normalnykh_pokazateley_mukotsiliarnogo_transporta_osnova_adekvatnogo_i_korrektnogo_ispol.html

40. Piccirillo JF, Edwards D, Haiduk A, Yonan C, Thawley SE. Psychometric and Clinimetric Validity of the 31-Item Rhinosinusitis Outcome Measure (RSOM-31). Am J Rhinol. 1995;9(6):297–308. https://doi.org/10.2500/105065895781808711.

41. Nesterova KI, Nesterov IA. Application of criteria of quality of life for the comparative analysis by working out of new methods of treatment in rhinology. Rossiiskaya Otorinolaringologiya. 2011;(6):110–114. (In Russ.) Available at: https://cyberleninka.ru/article/n/vliyanie-ultrazvukovoy-bespunktsionnoy-tehnologii-sanatsii-okolonosovyh-pazuh-na-kachestvo-zhizni-patsientov-pri-hronicheskih-gnoynyh.

42. Musienko A, Nesterova KI, Gileva OS, Iordanishvili AK, Muzikin MI, Nevterov AA et al. Ways to improve the quality of life in patients with partial adentia and chronic periodontitis associated with maxillary sinusitis at the stages of dental prosthetics. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2023;29(2):12–23. (In Russ.)